The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction
NCT06350487
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
154
Enrollment
OTHER
Sponsor class
Conditions
Heart Failure, Preserved Ejection Fraction
Interventions
DRUG:
SGLT2 inhibitor
Sponsor
Samsung Medical Center